Revium Rx develops advanced delivery systems for a variety of indications.

Its platform expands the therapeutic horizons of hard-to-treat diseases by enhancing, improving and unleashing the potential of encapsulated therapeutics.

Revium’s current pipeline encompasses antibiotics for antimicrobial-resistant bacteria, immune checkpoint inhibitor adjuvant for solid tumors, and a novel immunization platform.